Isohelix announced its GeneFiX™ Saliva RNA Collection Device is the technology of choice for COVID-19 testing by Precision Genetics, a healthcare technology company and high capacity molecular testing laboratory.
"We are proud that our GeneFix Saliva RNA Collection Device is being used as a valuable, dependable method at the Precision Genetics testing laboratory, where a wide variety of SARS-CoV-2 assays are being implemented to contribute to the global fight against COVID-19," said Tom Hole, CEO of Isohelix. "Precision Genetics reviewed various saliva collection kits and chose the GeneFix Saliva RNA Collection Device for its superior simplicity and reliable performance."
Saliva collection allows a person to expel their saliva into a tube, making it far less invasive than the nasopharyngeal (NP) collection method. In addition, saliva collection offers ease and convenience for more populations and demographics.
Subscribe to our e-Newsletters
Stay up to date with the latest news, articles, and events. Plus, get special offers
from Pharmaceutical Outsourcing – all delivered right to your inbox! Sign up now!
"Saliva collection not only reduces exposure to the SARS-CoV-2 virus for healthcare professionals supervising the collection process, but as importantly offers a less invasive and comfortable alternative for groups that might require this option," said Nate Wilbourne, CEO of Precision Genetics.
The GeneFix Saliva DNA/RNA Collection Devices maximize the yield and quality of the DNA and RNA collected, whilst offering long term stabilization at room temperature. The devices are easy to use and integrate seamlessly into most manual and HT processing kits, with 1 and 2d bar coding, automation friendly features all specified for leak proof mailing.